Source: BioCentury

Semma Therapeutics: July 2 Preclinical Quick Takes: Semma plans 2020 clinical trials of stem cell-derived islet products and more

Read full article »
Semma Therapeutics's Competitors | Semma Therapeutics's News | Semma Therapeutics's Financials
Stay up-to-date with the latest news on Semma Therapeutics
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Bastiano Sanna's photo - President & CEO of Semma Therapeutics

President & CEO

Bastiano Sanna

CEO Approval Rating

88/100

Read more
Stay up-to-date with the latest news on Semma Therapeutics